Literature DB >> 20093170

Comparative pharmacokinetics of baicalin in plasma after oral administration of Huang-Lian-Jie-Du-Tang or pure baicalin in MCAO and sham-operated rats.

Ming-fei Zeng1, Lin-mei Pan, Hua-xu Zhu, Qi-chun Zhang, Li-wei Guo.   

Abstract

A sensitive and specific HPLC method was developed to analyze baicalin in rat plasma. The author had compared the pharmacokinetics of baicalin after oral administration of HLJDT decoction or pure baicalin in MCAO and sham-operated rats. All the rats were divided into two groups, MCAO and sham-operated rats. Each group contained two subgroups: HLJDT decoction and pure baicalin subgroup. The HLJDT subgroup oral administration of HLJDT decoction extract 10.00 g/kg according to body weight (containing baicalin 400.00 mg/kg according to body weight), the pure baicalin subgroup received a gavages at a dosage of baicalin 400.00 mg/kg according to body weight too. The pharmacokinetics parameters were analyzed by kinetica. The results indicated that the pharmacokinetics of baicalin in rat plasma was non-linear and there were significant differences between different groups. No matter in MCAO or sham-operated rats, pure baicalin had shown better absorption than HLJDT decoction. Whether administration of pure baicalin or HLJDT decoction, the MCAO rats show better, quicker absorption of baicalin than sham-operated rats. It was good for baicalin to exert pharmacological effects on healed cerebrovascular diseases. The method had been applied successfully to pharmacokinetics of baicalin in rat plasma after oral administration of pure baicalin or HLJDT decoction. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093170     DOI: 10.1016/j.fitote.2010.01.004

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  15 in total

Review 1.  Treatment of cerebral ischemia with combination of bone marrow-derived mesenchymal stem cells and Chinese medicine.

Authors:  Ying Guan; Yong-hua Zhao
Journal:  Chin J Integr Med       Date:  2011-09-11       Impact factor: 1.978

2.  In Vivo Pharmacokinetics of Puerarin via Different Drug Administration Routes Based on Middle Cerebral Artery Occlusion Model.

Authors:  Pengyue Li; Jie Bai; Boyu Dong; Yang Lu; Shengwei Zhang; Shuang Guo; Ning Tan; Mengdi Zhao; Shouying Du; Puning Cao
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-08       Impact factor: 2.441

3.  Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO--MMP-9 Pathway.

Authors:  Hansen Chen; Binghe Guan; Xi Chen; Xingmiao Chen; Caiming Li; Jinhua Qiu; Dan Yang; Ke Jian Liu; Suhua Qi; Jiangang Shen
Journal:  Transl Stroke Res       Date:  2017-12-23       Impact factor: 6.829

4.  Pharmacokinetic comparison of berberine in rat plasma after oral administration of berberine hydrochloride in normal and post inflammation irritable bowel syndrome rats.

Authors:  Zipeng Gong; Ying Chen; Ruijie Zhang; Yinghan Wang; Yan Guo; Qing Yang; Haixian Zhang; Yu Dong; Xiaogang Weng; Shuangrong Gao; Xiaoxin Zhu
Journal:  Int J Mol Sci       Date:  2014-01-02       Impact factor: 5.923

5.  Comparative pharmacokinetics of baicalin, wogonoside, baicalein and wogonin in plasma after oral administration of pure baicalin, radix scutellariae and scutellariae-paeoniae couple extracts in normal and ulcerative colitis rats.

Authors:  Zhen-Qiu Zhang; Wei Liua; Li Zhuang; Jing Wang; Shuai Zhang
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

6.  Concentration-dependent inhibitory effect of Baicalin on the plasma protein binding and metabolism of chlorzoxazone, a CYP2E1 probe substrate, in rats in vitro and in vivo.

Authors:  Na Gao; Dan Zou; Hai-Ling Qiao
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

7.  Contribution of baicalin on the plasma protein binding displacement and CYP3A activity inhibition to the pharmacokinetic changes of nifedipine in rats in vivo and in vitro.

Authors:  Zhen-Yu Cheng; Xin Tian; Jie Gao; Hong-Meng Li; Lin-Jing Jia; Hai-Ling Qiao
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

8.  Exploratory Pharmacokinetics of Geniposide in Rat Model of Cerebral Ischemia Orally Administered with or without Baicalin and/or Berberine.

Authors:  Linmei Pan; Wenzhe Wang; Feiyan Shi; Jing Zhou; Meng Zhang; Huaxu Zhu; Mingfei Zeng
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-03       Impact factor: 2.629

9.  Pharmacokinetic-Pharmacodynamic Analysis on Inflammation Rat Model after Oral Administration of Huang Lian Jie Du Decoction.

Authors:  Wei Ren; Ran Zuo; Yao-Nan Wang; Hong-Jie Wang; Jian Yang; Shao-Kun Xin; Ling-Yu Han; Hai-Yu Zhao; Shu-Yan Han; Bo Gao; Hao Hu; Yuan-Jia Hu; Bao-Lin Bian; Nan Si
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

Review 10.  The Effects of Baicalin and Baicalein on Cerebral Ischemia: A Review.

Authors:  Wei Liang; Xiaobo Huang; Wenqiang Chen
Journal:  Aging Dis       Date:  2017-12-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.